Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Published Date: 21 Oct 2025

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

5.

Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot